This trial will test whether IV infusions of iron sucrose can improve iron stores in ovarian cancer patients before surgery, and reduce the need for transfusions of packed red blood cells during surgery.
- Iron-Deficiency Anemia
- Ovarian Cancer
1 Primary · 3 Secondary · Reporting Duration: Within 72 hours of surgery, up to 5 weeks on study
Side Effects for
1 Treatment Group
IV Iron Sucrose
1 of 1
9 Total Participants · 1 Treatment Group
Primary Treatment: Iron Sucrose · No Placebo Group · Phase 1 & 2
Who is running the clinical trial?
Age 18+ · Female Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there still positions open for participants in this trial?
"That's right, the listing on clinicaltrials.gov currently says that this study is recruiting patients. This particular trial was first advertised on 7/29/2019, and the most recent update was on 10/5/2022. They are hoping to find 21 volunteers for the 1 site location." - Anonymous Online Contributor